Combined with the results that Syncytin-1 had oncogenic potential in HCC (Figs. 1–3), it was highly suggested that Syncytin-1 might promote HCC development through an aberrantly regulated inflammation-activated signal pathway. Here, ERVW-1 is linked to hepatocellular carcinoma.